Balaji Solutions files draft papers with Sebi to raise funds via IPO
时间:2024-06-26 07:23:36 阅读(143)
IT hardware and mobile accessories firm Balaji Solutions has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO).The public issue consists of a fresh issue of equity shares worth up to Rs 120 crore and an offer-for-sale (OFS) of up to 75 lakh equity shares by promoter and promoter group entity, according to the draft red herring prospectus (DRHP).
Under the OFS, Rajendra Seksaria and Rajendra Seksaria HUF will offload shares.The offer also includes a reservation for subscriptions by eligible employees. The company may consider a pre-IPO placement aggregating up to Rs 24 crore. If such placement is completed, the fresh issue size will be reduced. Proceeds from its fresh issuance worth Rs 86.60 crore will be utilised for funding incremental working capital requirements and general corporate purposes.
Balaji Solutions is an IT hardware and peripherals and mobile accessories company engaged in the business of manufacturing and branding products under its flagship brand “Foxin”.
Also read| Balaji Speciality Chemicals files IPO papers with SEBI, plans to raise Rs 250 crore via fresh issue
The company’s revenue decreased to Rs 482.25 crore for the financial year 2022 from Rs 483.48 crore for the financial year 2021, besides, profit after tax dropped to Rs 15.39 crore in FY22 from Rs 16.25 crore in the preceding fiscal.IDBI Capital Markets and Securities and Affinity Global Capital Market are the books running lead managers. The equity shares are proposed to be listed on BSE and NSE.
猜你喜欢
- Market HIGHLIGHTS- Sensex ends 379 pts up, Nifty at 17,829; Reliance Industries, HDFC twins top index gainers
- LTIMindtree secures entry in Nifty 50 index; stock jumps over 2% today
- Markets maintain positive trend for six weeks, 4% away from record-high; global cues, earnings to drive markets
- Nifty charts showing indecisiveness between bulls, bears; REC, Ultratech Cement, Mphasis among stocks to buy
- Market volatility, regulatory diktats play part- New client additions by brokers see marked decline
- Nifty support at 17000, VIX needs to slip below 20 to witness cool-off; Buy these 2 shares for gains
- Lupin gets USFDA approval for suspension to treat allergic conjunctivitis
- Market texture bullish but mildly overbought, Nifty support at 18050-18000; M&M, HCL Tech among top stocks to buy
- Markets in a short term downtrend; sell Grasim, IRCTC to protect gains